By Mill Chart
Last update: Mar 22, 2024
Which stocks are gapping on Friday?
Ticker | Change | Comment |
---|---|---|
BCAN | 11.0K% | During Friday's session, BYND CANNASOFT ENTERPRISES's (NASDAQ:BCAN) stock price showed a remarkable increase of 11.0K%, reaching $2.28 with a notable 10.0K% gap. In the last month the share price dropped with 90.54%. |
MBRX | 1.0K% | MOLECULIN BIOTECH INC's (NASDAQ:MBRX) shares rose 1.0K% to $5.85 with a gap of 1.0K% during Friday's session. The stock is trading 35.0% lower than 3 months ago. |
ATER | 1.0K% | ATERIAN INC's (NASDAQ:ATER) shares rose 1.0K% to $3.06 with a gap of 750.0% during Friday's session. In the last month the stock lost 26.77%. |
MLGO | 800.0% | MICROALGO INC's (NASDAQ:MLGO) stock price is advancing with 800.0% to a price of $3.87 with a gap of 650.0%. Shareholders saw the stock price going 44.81% lower in the past month. |
OTLK | 32.45% | Exciting news for OUTLOOK THERAPEUTICS INC's (NASDAQ:OTLK) stock! It advanced 32.45% to $9.32 in today's session, accompanied by a substantial gap of 16.67%. The stock is trading 68.5% higher than 6 months ago. |
BIOL | 27.07% | Exciting news for BIOLASE INC's (NASDAQ:BIOL) stock! It advanced 27.07% to $0.19 in today's session, accompanied by a substantial gap of 19.83%. The stock is trading 87.07% lower than 3 months ago. |
WS | 20.3% | WORTHINGTON STEEL INC's (NYSE:WS) shares surged 20.3% to $38.4 with a remarkable gap of 6.32%. Yesterday the company had a press release: Worthington Steel Declares Quarterly Dividend. |
FRSX | 15.31% | Exciting news for FORESIGHT AUTONOMOUS-SP ADR's (NASDAQ:FRSX) stock! It advanced 15.31% to $1.13 in today's session, accompanied by a substantial gap of 10.69%. The stock is trading 56.25% lower than 6 months ago. |
DNTH | 13.92% | During Friday's session, DIANTHUS THERAPEUTICS INC's (NASDAQ:DNTH) stock price showed a remarkable increase of 13.92%, reaching $31.83 with a notable 3.97% gap. In the last 3 months the stock gained 144.0%. |
CAPT | 9.56% | CAPTIVISION INC's (NASDAQ:CAPT) shares surged 9.56% to $6.19 with a remarkable gap of 6.37%. The stock is trading 68.66% higher than 3 months ago. |
For the full gap up stocks list go to our gap up stocks screener.
Ticker | Change | Comment |
---|---|---|
CUTR | -29.78% | CUTERA INC's (NASDAQ:CUTR) stock price is declining with 29.78% to a price of $1.61 with a gap of 36.53%. Yesterday the company had a press release: Cutera Announces Fourth Quarter and Full-Year 2023 Financial Results Along with 2024 Outlook. |
SINT | -28.38% | SINTX TECHNOLOGIES INC's (NASDAQ:SINT) shares experienced a 28.38% decline to $0.1 during Friday's session, accompanied by a 39.23% gap. Shareholders saw the stock price going 71.06% lower in the past 3 months. |
SOUNW | -22.16% | During Friday's session, SOUNDHOUND AI INC's (NASDAQ:SOUNW) stock price decreased by 22.16% to $2.67 with a significant 43.33% gap. The stock is trading 29.43% higher than a month ago. |
RETO | -21.93% | RETO ECO-SOLUTIONS INC's (NASDAQ:RETO) shares declined by 21.93% to $1.46, showing a 33.93% gap in today's session. A press release (ReTo Regained Compliance with Nasdaq's Minimum Bid Price Requirement and Received Extension on Compliance with Nasdaq's Minimum Stockholders' Equity Rule) was released two days ago. |
NKTX | -21.65% | Today, NKARTA INC's (NASDAQ:NKTX) stock experienced a 21.65% fall to $10.17 with a 34.53% gap. In the last month the share price increased with 36.63%. |
ATNF | -19.54% | In today's session, 180 LIFE SCIENCES CORP's (NASDAQ:ATNF) stock witnessed a 19.54% fall to $2.8 with a 24.0% gap. In the last 6 months the share price dropped with 67.91%. |
LULU | -18.61% | Unfavorable news for LULULEMON ATHLETICA INC's (NASDAQ:LULU) stock! It witnessed a 18.61% decline to $389.71 in today's session, along with a 19.51% gap. In the last 6 months the stock gained 23.4%. |
LXEH | -18.47% | LIXIANG EDUCATION HOLDIN-ADR's (NASDAQ:LXEH) shares fell 18.47% to $0.6 with a gap of 88.05%. The stock is trading 85.77% lower than a month ago. |
GNS | -17.6% | GENIUS GROUP LTD's (NYSEARCA:GNS) shares recorded a 17.6% decline to $0.43, with a notable 28.81% gap during today's session. In the last month the stock gained 51.25%. |
YTEN | -17.26% | YIELD10 BIOSCIENCE INC's (NASDAQ:YTEN) shares recorded a 17.26% decline to $0.36, with a notable 58.0% gap during today's session. A press release (USDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United States) was released yesterday. |
To see the full list of gap down stocks you can use our gap down stocks screener.
OUTLOOK THERAPEUTICS INC
NASDAQ:OTLK (4/26/2024, 7:08:27 PM)
After market: 8.31 -0.12 (-1.42%)8.43
+0.24 (+2.93%)
ISELIN, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first...
With the medical care industry always liable for negative surprises, you might as well go for big upside with under-$10 biotech stocks.
Positive opinion serves as a basis for final decision for potential authorization from the European Commission (EC), expected within 67 days ISELIN, N.J.,...
ISELIN, N.J., March 18, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of bevacizumab for the treatment of retinal diseases in the US and the EU, today announced that it has closed its previously announced private placement, for upfront gross proceeds of approximately $60 million from the issuance and sale of shares of the Company’s common stock and accompanying warrants, before deducting placement agent fees and offering expenses. Outlook Therapeutics has the potential to receive additional gross proceeds of up to $99 million upon the full cash exercise of the warrants issued in the private placement, before deducting placement agent fees and offering expenses.
ISELIN, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK) (the “Company”), a biopharmaceutical company working to...
Although speculative stocks under $1 are by their very nature extremely risky, these ideas might have enough to go the distance.
Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money.
Shares of Outlook Therapeutics (OTLK) climbed 13% after Chardan upgraded the stock to buy, citing the company’s recent private placement and the full cash exerc
NORSE EIGHT underway with first subject dosed and additional clinical sites beginning enrollment Continue to expect planned resubmission of the ONS-5010...
NORSE EIGHT clinical trial is being conducted under Special Protocol Assessment (SPA) from FDA to support expected resubmission of the ONS-5010 Biologics...